PDE5A
Basic information
Region (hg38): 4:119494397-119628804
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (76 variants)
- not_provided (15 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE5A gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001083.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 72 | 79 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 72 | 10 | 5 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PDE5A | protein_coding | protein_coding | ENST00000354960 | 21 | 134597 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000106 | 1.00 | 125701 | 0 | 47 | 125748 | 0.000187 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.10 | 327 | 453 | 0.722 | 0.0000224 | 5828 |
Missense in Polyphen | 96 | 169.63 | 0.56595 | 2206 | ||
Synonymous | 1.33 | 136 | 157 | 0.865 | 0.00000777 | 1532 |
Loss of Function | 4.25 | 16 | 47.6 | 0.336 | 0.00000235 | 588 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000489 | 0.000460 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.000232 | 0.000231 |
European (Non-Finnish) | 0.000216 | 0.000211 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000113 | 0.0000980 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. This phosphodiesterase catalyzes the specific hydrolysis of cGMP to 5'- GMP (PubMed:9714779, PubMed:15489334). Specifically regulates nitric-oxide-generated cGMP (PubMed:15489334). {ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9714779}.;
- Pathway
- Purine metabolism - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Phosphodiesterases in neuronal function;Purine nucleotides nucleosides metabolism;Hemostasis;cGMP effects;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis
(Consensus)
Recessive Scores
- pRec
- 0.238
Intolerance Scores
- loftool
- 0.457
- rvis_EVS
- 1.05
- rvis_percentile_EVS
- 91.34
Haploinsufficiency Scores
- pHI
- 0.178
- hipred
- Y
- hipred_score
- 0.641
- ghis
- 0.475
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.443
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pde5a
- Phenotype
Gene ontology
- Biological process
- signal transduction;positive regulation of cardiac muscle hypertrophy;regulation of nitric oxide mediated signal transduction;negative regulation of T cell proliferation;positive regulation of MAP kinase activity;cGMP catabolic process;negative regulation of cardiac muscle contraction;relaxation of cardiac muscle;positive regulation of oocyte development
- Cellular component
- cellular_component;cytosol
- Molecular function
- 3',5'-cyclic-nucleotide phosphodiesterase activity;protein binding;cGMP binding;metal ion binding;3',5'-cyclic-GMP phosphodiesterase activity